Novartis Cash Flow from Operations

NVS -- USA Stock  

Fiscal Quarter End: December 31, 2019  

Novartis cash-flow-from-operations fundamental analysis lookup allows you to check this and other indicators for Novartis AG or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Novartis Cash Flow from Operations Analysis

Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.
 2009 2010 2018 2019 (projected)
Book Value per Share 33.92  22.21  25.54  30.36 
Asset Turnover 0.38  0.55  0.50  0.45 
Operating Cash Flow 
More About Cash Flow from Operations | All Equity Analysis
Novartis Cash Flow from Operations  =
13.74 B
Novartis ValuationFundamentalsBuy or Sell

Novartis Cash Flow from Operations Over Time Pattern

 Novartis Net Cash Flow from Operations 

About Cash Flow from Operations

Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about company having enough liquid resources to meet current and long term debt obligations.
Compare to competition

Novartis Cash Flow from Operations Assessment

Net Loss Income from Discontinued Operations
In accordance with recently published financial statements Novartis AG has 13.74 B in Cash Flow from Operations. This is 2505.89% higher than that of the Healthcare sector, and significantly higher than that of Drug Manufacturers?General industry, The Cash Flow from Operations for all stocks is 1314.71% lower than the firm.

Novartis Cash Flow from Operations Peer Comparison

  Cash Flow from Operations 
      Novartis Comparables 
Novartis is regarded second in cash flow from operations category among related companies.

Novartis current financial ratios